Advertisement
Loading...

SNDL Inc.

SNDL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.43
$-0.03(-2.05%)
U.S. Market opens in 28h 24m

SNDL Inc. (SNDL) Stock Overview

Explore SNDL Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap370.7M
P/E Ratio-46.44
EPS (TTM)$-0.03
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$1.36
3 Months$1.54
1 Year Target$2.02

SNDL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SNDL Inc. (SNDL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.98, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -46.44 and a market capitalization of 370.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.05%
5-Day Change
N/A
1-Month Change
-6.54%
3-Month Change
-4.67%
6-Month Change
-14.88%
Year-to-Date (YTD) Change
-13.86%
1-Year Change
11.72%
3-Year Change
-15.38%
5-Year Change
-81.06%
All-Time (Max) Change
-98.31%

Contact Information

https://www.sndlgroup.com
14039485227
919–11 Avenue SW, Calgary, AB, T2R 1P3

Company Facts

2,604 Employees
IPO DateAug 1, 2019
CountryCA
Actively Trading

Frequently Asked Questions